By Inna Kowalsky, founder of Cosmetics China Agency.
The facts
On 26 September 2026, Sina Finance reported two small transactions that most foreign brand owners will scroll past. They should not.
L’Oréal, through an affiliated fund, subscribed roughly RMB 2.35 million for a 4.43% stake in the parent company of 蒂洛薇, a young Chinese base-makeup brand almost nobody outside China has heard of. In the same window, Proya took 19% of Shanghai Kedai Biotech, the company behind the skincare brand 毕生之研, for about RMB 3.13 million. For Proya, that is the second investment in an outside brand in under a year.
Put those numbers next to what the same companies do when they are serious. Proya paid RMB 428 million for 38.45% of the makeup brand Flower Knows (花知晓) in September 2025, then another RMB 351 million in May 2026 to reach 51% and consolidate it into its accounts. Henkel bought Olaplex outright in March 2026 for USD 1.4 billion.
Two million yuan and four hundred million yuan are not the same kind of decision. Chinese analysts have a clean way of putting it: the small stakes are 低成本试水, low-cost testing of the water, and 预留战略卡位, reserving a strategic position. The control deals are 当期业绩补血, an immediate transfusion into this year’s earnings.
What this actually means
I have watched foreign brands misread this for two years, so let me be blunt about it.
The story is not “L’Oréal invests in China”. L’Oréal has invested in China since before most of the brands reading this had a Tmall store. The story is the size of the cheque. Two and a half million yuan is not a strategic acquisition. It is the price of an option, and an option is what you buy when you have decided that you cannot reliably pick the winner yourself.
That is the admission buried in these filings. The global groups are extremely good at scaling a brand once it works. They have been consistently mediocre at spotting which Chinese brand is about to work, because that judgment now depends on reading Xiaohongshu comment sections and Douyin sell-through data in Chinese, weekly, at a level of granularity no Paris or New York committee operates at.
So they have changed instrument. Instead of betting big and late, they are buying cheap and early, in several places at once, and waiting to see which one moves. Proya, a Chinese company with the same information problem but a shorter distance to the data, is doing precisely the same thing.
Notice also what neither of them is doing. Neither is launching a new in-house brand into the C-beauty segment. That option is available to both, and both declined it. When the two most capable operators in the market would rather own 4% of someone else’s brand than 100% of one they build themselves, that is a judgment about how hard it has become to start a beauty brand in China from zero.
One caution before anyone over-reads this. These are minority positions with no consolidation and no operational control. Most of them will go nowhere, which is the entire point of a portfolio of options. Do not mistake a RMB 2.35 million cheque for a validation of a brand’s business model.
What it changes for your brand
If you run a foreign beauty brand in China, three things follow from this, and none of them are obvious.
First, your competitive set just got better capitalised. The young Chinese brand undercutting you on Douyin is no longer necessarily a scrappy independent burning through a seed round. It may now have a global group’s fund on its cap table, which changes how long it can afford to lose money in your price band.
Second, being acquired or funded by a Chinese group is now a real strategic option for mid-size Western brands, and almost nobody is preparing for it. Chinese groups have shifted from volume expansion to buying niche foreign brands, mirroring exactly what L’Oréal and Estée Lauder spent thirty years doing. If your brand has a distinctive formula story and a plateauing home market, you are a target profile. That is not a threat. It is the most realistic liquidity event some of these brands will ever see, and it goes far better when the brand has a clean, documented China presence rather than a grey-market one.
Third, the window on “wait and see” is closing. The recovery is real: Estée Lauder reported 9% organic net sales growth in mainland China for its 2026 financial year, with market share gains for six consecutive quarters. Capital allocators do not put money into a market they think is dying. They put small, frequent, early money into one they think is about to sort itself into winners and losers.
A conversation I had this week
Client · Export director, European dermocosmetics brand
Client
We’ve been approached by a Chinese group about a minority investment. Flattering, but is it a trap?
Inna
Not a trap. But understand what they’re buying. At a small percentage, they’re buying information and a right of first look, not your company.
Client
So the money isn’t the point?
Inna
The money is never the point at that size. The distribution access that usually comes attached is the point. Ask what doors open in writing, not in the meeting.
Client
And if we say no?
Inna
Then build the China numbers anyway. The brands that get good offers are the ones that already had a clean, profitable, documented presence. Nobody pays a premium for potential here.
Client
That’s less romantic than I hoped.
Inna
China rarely is. It’s just arithmetic that happens in Mandarin.
Conversation reconstructed and anonymised. I have some version of it most weeks.
What to do about it, in order
Nothing in this news requires you to change your media plan tomorrow. It should change three slower things.
Start by finding out who actually owns your three closest Chinese competitors, and whether that changed in the last eighteen months. Most foreign brands cannot answer this, and it is public information. If a global fund appeared on a competitor’s cap table, expect that competitor to get more aggressive on price and on KOL budgets, not less.
Then get your own numbers into a state where they could survive a due diligence conversation you did not initiate. Clean revenue split by channel, real contribution margin after commission and returns, a member base you own rather than rent, and no dependence on grey-market volume you cannot explain. Brands that have this get approached. Brands that do not, get ignored, whatever their Instagram looks like.
Finally, decide honestly whether you are building an operating business in China or an asset someone will want to buy. They require different spending patterns, and pretending you are doing both is how mid-size brands run out of money in month eighteen. Our China marketing team starts most engagements with exactly that question, and our Tmall operations team builds the numbers that make either answer defensible.
The open question
Some brand owners read a wave of small stakes as a signal to hold on, stay independent, and wait for a better valuation once the market sorts itself out. Others read it as the last window to be bought while the buyers are still curious rather than selective. On your own brand, which of those two are you actually playing, and does your China budget match it? Tell us in the comments, or write to us directly.
Inna Kowalsky is the founder and Chief Beauty Officer of Cosmetics China Agency, an independent, beauty-only agency in Shanghai. She has spent fifteen years watching foreign beauty brands enter, misread and occasionally win the Chinese market. LinkedIn: linkedin.com/in/innakochanzhi.
